SPIRE Bioventures and Typlit Inc. Sign consulting and advisory agreement
Tuesday, August 30th, 2016 - SPIRE Bioventures is delighted to announce that it has signed an agreement with Typlit Inc., a start-up that has developed an innovative device for ligation and occlusion of tubular structures in laparoscopic surgery.
Typlit Inc. announced last month that Dr. James Lau, director of the Goodman...
Hicham Jorio, SPIRE Bioventures' mentor and partner participates and Speaks at the Qatar International Medical Conference
Hepatitis C, HIV saliva-based detection technology to be showcased at medical meet
SPIRE Bioventures participates in the Endeavor Investor Network event in San Francisco
SPIRE Bioventures has attended the Endeavor Investor Network event in San Francisco. This was a great opportunity for the SPIRE team to meet some incredible start-ups in the Health Science industry as well as network with global funds.